Search Results
Search results for "Vir Biotechnology"
Results found for "Vir Biotechnology"
Posts (29)
- First in Human: Early-stage COVID therapies hold promise against omicron variant
December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and vaccine-makers race to test their shots against the variant, the monoclonal antibody sotrovimab from Vir showing preclinical efficacy against all COVID-19 variants, including the delta and omicron mutations, Vir
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development
Other Pages (27)
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr. GPCR Ecosystem Unlock the Full Dr.
- Dr. Timo De Groof | Dr. GPCR Ecosystem
Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry
- Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem
oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes
